Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
11/04/2024 | 17h17 | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
11/04/2024 | 17h17 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
11/04/2024 | 17h08 | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC | TSX:BHC | Bausch Health Companies Inc |
11/04/2024 | 17h03 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
03/04/2024 | 18h08 | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
03/04/2024 | 18h05 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
03/04/2024 | 18h04 | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC | TSX:BHC | Bausch Health Companies Inc |
03/04/2024 | 18h01 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
01/11/2023 | 15h44 | PR Newswire (Canada) | L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
01/11/2023 | 15h43 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
01/11/2023 | 15h43 | PR Newswire (Canada) | Suspension de la négociation par l'Organisme canadien de réglementation des investissements - BHC | TSX:BHC | Bausch Health Companies Inc |
01/11/2023 | 15h40 | PR Newswire (Canada) | Canadian Investment Regulatory Organization Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
31/05/2023 | 14h00 | PR Newswire (US) | OraPharma and Alex Rodriguez Team Up to Raise Awareness About the Importance of Managing Gum Disease | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 19h34 | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 19h33 | PR Newswire (Canada) | IIROC Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 19h18 | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 19h17 | PR Newswire (Canada) | IIROC Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 18h47 | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 18h46 | PR Newswire (Canada) | IIROC Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 18h44 | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 18h43 | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 18h43 | PR Newswire (Canada) | ttIIROC Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
17/05/2023 | 18h41 | PR Newswire (Canada) | IIROC Trading Halt - BHC | TSX:BHC | Bausch Health Companies Inc |
03/05/2023 | 12h58 | PR Newswire (Canada) | RYALTRIS®, a new combination prescription nasal spray for moderate to severe seasonal allergic rhinitis (SAR), now available across Canada | TSX:BHC | Bausch Health Companies Inc |
03/05/2023 | 12h58 | PR Newswire (Canada) | RYALTRIS(MD), une nouvelle association sous ordonnance en pulvérisateur nasal pour la rhinite allergique saisonnière (RAS) d'intensité modérée à grave, est maintenant disponible partout au Canada | TSX:BHC | Bausch Health Companies Inc |
22/12/2022 | 12h59 | PR Newswire (Canada) | First tazarotene lotion treatment for acne vulgaris, ARAZLO™ (tazarotene lotion, 0.045%), now available to patients through Quebec, Ontario, Alberta, Saskatchewan and federal NIHB public drug plans | TSX:BHC | Bausch Health Companies Inc |
22/12/2022 | 12h59 | PR Newswire (Canada) | ARAZLOMC (lotion de tazarotène, 0,045 %), la première lotion à base de tazarotène indiquée pour le traitement de l'acné vulgaire, est maintenant offerte aux patients du Québec, de l'Ontario, de l'Alberta et de la Saskatchewan dans le cadre des régi | TSX:BHC | Bausch Health Companies Inc |
17/11/2022 | 19h08 | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - BHC | TSX:BHC | Bausch Health Companies Inc |
17/11/2022 | 19h06 | PR Newswire (Canada) | IIROC Trade Resumption - BHC | TSX:BHC | Bausch Health Companies Inc |
17/11/2022 | 19h04 | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - BHC | TSX:BHC | Bausch Health Companies Inc |